Structure-dependent Impairment of Intracellular Apolipoprotein E4 Trafficking and Its Detrimental Effects Are Rescued by Small-molecule Structure Correctors-Reference-Cited by-同舟云学术

Structure-dependent Impairment of Intracellular Apolipoprotein E4 Trafficking and Its Detrimental Effects Are Rescued by Small-molecule Structure Correctors

Published:2011-05 Issue:19 Volume:286 Page:17217-17226
ISSN:0021-9258
Container-title:Journal of Biological Chemistry
language:en
Short-container-title:Journal of Biological Chemistry

Author:

Brodbeck Jens,McGuire Jim,Liu Zhaoping,Meyer-Franke Anke,Balestra Maureen E.,Jeong Dah-eun,Pleiss Mike,McComas Casey,Hess Fred,Witter David,Peterson Scott,Childers Matthew,Goulet Mark,Liverton Nigel,Hargreaves Richard,Freedman Stephen,Weisgraber Karl H.,Mahley Robert W.,Huang Yadong

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry

Reference55 articles.

1. Apolipoprotein E: Cholesterol Transport Protein with Expanding Role in Cell Biology

2. Apolipoprotein E: Structure-Function Relationships

3. Gene Dose of Apolipoprotein E Type 4 Allele and the Risk of Alzheimer's Disease in Late Onset Families

4. Association of apolipoprotein E allele 4 with late-onset familial and sporadic Alzheimer's disease

5. Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease.

Cited by 88 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New insights in lipid metabolism: potential therapeutic targets for the treatment of Alzheimer’s disease;Frontiers in Neuroscience;2024-09-11

2. Apolipoprotein E in Alzheimer’s Disease: Focus on Synaptic Function and Therapeutic Strategy;Molecular Neurobiology;2024-08-31

3. Drugs targeting APOE4 that regulate beta‐amyloid aggregation in the brain: Therapeutic potential for Alzheimer's disease;Basic & Clinical Pharmacology & Toxicology;2024-07-17

4. Multifaceted roles of APOE in Alzheimer disease;Nature Reviews Neurology;2024-06-21

5. APOE4 is a Risk Factor and Potential Therapeutic Target for Alzheimer's Disease;CNS & Neurological Disorders - Drug Targets;2024-03